Hap Trading, LLC Aquestive Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.57 $22,272 - $89,436	-34,800 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.28 - $4.26 $40,128 - $74,976	17,600 Added 102.33%	34,800 $3,000
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $18,081 - $31,213	4,900 Added 39.84%	17,200 $5,000
Q3 2021 Nov 10, 2021	BUY	$3.25 - $4.66 $39,975 - $57,318	12,300 New	12,300 $10,000
Q2 2021 Aug 11, 2021	SELL	$3.29 - $5.21 $47,376 - $75,024	-14,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.17 - $6.73 $60,048 - $96,912	14,400 New	14,400 $6,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $200M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.